2022
DOI: 10.1016/j.bjps.2021.11.033
|View full text |Cite
|
Sign up to set email alerts
|

A multi-centred sequential trial comparing PEGASUS, an intervention to promote shared decision making about breast reconstruction with usual care

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 30 publications
0
6
0
Order By: Relevance
“… 17 The only intervention study to look at outcomes up to 12 months, is Paraskeva et al’s 2022 sequential trial looking at patients considering breast reconstruction. 22 Notably, the reduction of decision regret for patients exposed to the SDM intervention in this study, was not sustained at 12 months. Overall, existing evidence tells us that patients want SDM.…”
Section: Introductionmentioning
confidence: 60%
See 1 more Smart Citation
“… 17 The only intervention study to look at outcomes up to 12 months, is Paraskeva et al’s 2022 sequential trial looking at patients considering breast reconstruction. 22 Notably, the reduction of decision regret for patients exposed to the SDM intervention in this study, was not sustained at 12 months. Overall, existing evidence tells us that patients want SDM.…”
Section: Introductionmentioning
confidence: 60%
“…At the time of writing, only one paper extends follow-up to 6 months post-treatment 17. The only intervention study to look at outcomes up to 12 months, is Paraskeva et al’s 2022 sequential trial looking at patients considering breast reconstruction 22. Notably, the reduction of decision regret for patients exposed to the SDM intervention in this study, was not sustained at 12 months.…”
Section: Introductionmentioning
confidence: 81%
“…Several decision aids have been developed to help women make decisions about breast reconstruction surgery 45 including, most recently, BRECONDA 46 and PEGASUS 47 . These, in particular, BRECONDA, have been shown to improve satisfaction with information and reduce decisional conflict in well designed clinical trials 46 .…”
Section: Discussionmentioning
confidence: 99%
“…There is no official costeffectiveness acceptability threshold in Norway. The 2015-2016 Norwegian government white paper on priority setting in the healthcare sector discusses a base threshold of 275,000 NOK (Norwegian Government, 2016). The base threshold may increase up to 825,000 NOK, depending on the patient groups' expected loss of QALYs under the current treatment strategy relative to the age-matched general population (absolute prognosis loss).…”
Section: Cost-effectiveness Acceptability Thresholdmentioning
confidence: 99%
“…Studies have shown that biomedical interventions, such as medical and surgical procedures to correct or ameliorate appearance differences, may improve social confidence (Myhre, Råbu & Feragen, 2021). However, biomedical interventions do not guarantee enhanced psychosocial functioning and therefore psychological interventions have evolved as an adjunct or alternative to biomedical approaches (Bemmels, Biesecker, Schmidt, Krokosky, Guidotti & Sutton, 2013; Paraskeva, Tollow, Clarke et al ., 2021; Rumsey & Harcourt., 2007). Psychosocial support for adolescents with a visible difference typically involves a wide range of therapeutic approaches and techniques drawn from cognitive behavioral therapy (CBT), social skills training (SST), and acceptance and commitment therapy (Harcourt, Hamlet, Feragen et al ., 2018).…”
Section: Introductionmentioning
confidence: 99%